Credit Suisse Group Reaffirms Outperform Rating for AcelRx Pharmaceuticals (NASDAQ:ACRX)

Retrieved on: 2019-07-24 16:15:00

Tags for this article:

Click the tags to see associated articles and topics

Credit Suisse Group Reaffirms Outperform Rating for AcelRx Pharmaceuticals (NASDAQ:ACRX). View article details on hiswai:

Excerpt

<div><b>WINTON GROUP</b> Ltd purchased a new position in shares of AcelRx Pharmaceuticals during the second quarter worth $40,000. Raymond James ...</div>

Article found on:

View Original Article